Targeting Type 1 Diabetes
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
Targeting Type 1 Diabetes
-
Narrated by:
-
Written by:
About this listen
Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level.
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Featured guests:
Madison Carter is an investigative journalist with 11Alive News, an NBC affiliate in Atlanta, GA. She's living with type 1 diabetes.
Aaron Kowalski is the President and CEO of Breakthrough T1D.
Felicia Pagliuca leads research in cell and genetic therapies at Vertex Pharmaceuticals.
Doug Melton leads investigations into treatments for type 1 diabetes at Vertex Pharmaceuticals. He is renowned for his stem cell research at Harvard University. Read more about Vertex's approach to targeting type 1 diabetes.
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.